Xyratex (Nasdaq: XRTX ) is expected to report Q2 earnings on July 1. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Xyratex's revenues will compress -36.9% and EPS will shrink to a loss.
The average estimate for revenue is $203.2 million. On the bottom line, the average EPS estimate is -$0.05.
Last quarter, Xyratex booked revenue of $195.6 million. GAAP reported sales were 34% lower than the prior-year quarter's $295.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.13. GAAP EPS were -$0.19 for Q1 versus $0.38 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 18.9%, 100 basis points better than the prior-year quarter. Operating margin was -2.9%, 650 basis points worse than the prior-year quarter. Net margin was -2.6%, 630 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $861.1 million. The average EPS estimate is $0.08.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 256 members out of 275 rating the stock outperform, and 19 members rating it underperform. Among 70 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 64 give Xyratex a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Xyratex is outperform, with an average price target of $11.00.
Is Xyratex the best tech stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Xyratex to My Watchlist.